IMMUNE THROMBOCYTOPENIA
Clinical trials for IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost platelet counts in ITP patients
Disease control Not yet recruitingThis study tests different doses of zanubrutinib combined with high-dose dexamethasone in 60 adults newly diagnosed with immune thrombocytopenia (ITP), a condition causing low platelet counts and bleeding. The goal is to find the safest and most effective dose to raise platelet l…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 17, 2026 10:38 UTC
-
Engineered immune cells take on lupus and more
Disease control Not yet recruitingThis early study tests a new treatment called CD19 UCAR-T cell therapy for people with autoimmune diseases like lupus, vasculitis, and Sjögren's syndrome. The therapy uses a patient's own immune cells, modified to target and calm the overactive immune system. The main goals are t…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New study tracks Real-World use of eltrombopag for low platelet disorder
Knowledge-focused Not yet recruitingThis study looks at how eltrombopag is used in routine medical practice for adults with primary immune thrombocytopenia (ITP), a condition causing low platelet counts. Researchers will collect data from doctors in the US, UK, and Germany on about 150 patients who have already tri…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 10:41 UTC
-
Blood test breakthrough: new clues to solve low platelet mystery
Knowledge-focused Not yet recruitingThis study looks at two genes (IL-1β and IL-33) in 300 adults with low platelets caused by either primary ITP or lupus. Researchers want to see if these gene activity levels can help tell the two conditions apart and improve diagnosis. Participants give a blood sample, but no tre…
Matched conditions: IMMUNE THROMBOCYTOPENIA
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated May 17, 2026 10:39 UTC